|
?:authorAffiliation
|
-
[\'Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH, United States.\', \'Department of Zoonoses, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.\', \'Division of Medical Laboratory Science, School of Health and Rehabilitation Sciences, The Ohio State University, Columbus, OH, United States.\', \'The James Comprehensive Cancer Center, Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, OH, United States.\', \'Division of Pulmonary Medicine, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, United States.\', \'Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.\', \'Marker Therapeutics Inc., Houston, TX, United States.\', \'Department of Veterinary Biosciences, College of Veterinary Medicine, Ohio State University, Columbus, OH, United States.\', \'Infectious Diseases Institute, The Ohio State University, Columbus, OH, United States.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}